ATIVAN(LORAZEPAM) - 美国FDA药品数据库

药品名称	ATIVAN
申请号	018140	产品号	002
活性成分	LORAZEPAM	市场状态	处方药
剂型或给药途径	INJECTABLE;INJECTION	规格	4MG/ML
治疗等效代码	AP	参比药物	是
批准日期	Approved Prior to Jan 1, 1982	申请机构	WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD
化学类型	New dosage form	审评分类	Standard review drug

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
无
历史专利信息
无

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
018140	040	AP	2016/05/27	Labeling Revision
018140	039	AP	2015/10/02	Manufacturing Change or Addition
018140	038	AP	2016/04/18	Manufacturing Change or Addition
018140	028	AP	2006/11/29	Labeling Revision
018140	027	AP	2001/12/12	Labeling Revision
018140	026	AP	2000/09/26	Labeling Revision
018140	025	AP	1997/11/04	Manufacturing Change or Addition
018140	024	AP	1998/10/16	Manufacturing Change or Addition
018140	023	AP	1996/09/26	Manufacturing Change or Addition
018140	022	AP	1996/03/19	Labeling Revision
018140	021	AP	1995/03/08	Expiration Date Change
018140	020	AP	1995/01/06	Control Supplement
018140	019	AP	1993/09/29	Package Change
018140	018	AP	1993/09/29	Package Change
018140	017	AP	1993/06/03	Control Supplement
018140	016	AP	1992/08/18	Package Change
018140	015	AP	1991/06/26	Manufacturing Change or Addition
018140	014	AP	1991/01/02	Manufacturing Change or Addition
018140	013	AP	1989/11/03	Manufacturing Change or Addition
018140	012	AP	1996/03/19	Labeling Revision
018140	011	AP	1996/03/19	Labeling Revision
018140	010	AP	1989/06/13	Manufacturing Change or Addition
018140	009	AP	1996/03/19	Labeling Revision
018140	008	AP	1987/04/13	Labeling Revision
018140	007	AP	1987/04/24	Manufacturing Change or Addition
018140	006	AP	1984/02/14	Manufacturing Change or Addition
018140	005	AP	1984/02/14	Control Supplement
018140	004	AP	1983/06/14	Package Change
018140	003	AP	1997/09/05	New or Modified Indication
018140	002	AP	1981/02/02	Expiration Date Change
018140	001	AP	1980/09/09	Labeling Revision
018140	000	AP	1980/07/25	Approval